Publications on Disease research from Merck & Co.
A filtered view. Show the full list.
Refine
Listings
-
ArticleBioorganic & medicinal chemistry letters
Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleJournal of medicinal chemistry
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
Clinical trial reportJournal of medicinal chemistry
Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer Immunotherapy
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleJournal of medicinal chemistry
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS infectious diseases
Activity Refinement and Property Assessment of Peptidomimetics with Potent Antimalarial Activity That Target Plasmepsin V
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS infectious diseases
Allosteric Crosstalk between Inhibitor Binding Sites Drives Enhanced Islatravir Susceptibility in F227C HIV-1 Reverse Transcriptase
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS medicinal chemistry letters
Discovery of Potent 1,3-Cyclobutane-Containing Dual A2A/A2B Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleNature communications
AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleNature medicine
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleScience (New York, N.Y.)
Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticlePLoS pathogens
Dual plasmepsin IX and X inhibitors are refractory to development of resistance
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleFrontiers in oncology
Multi-parameter optimization of a novel anti-TROP2 MMAE antibody-drug-conjugate for solid tumor therapy
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleBioorganic & medicinal chemistry letters
Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activity
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleBiotechnology reports (Amsterdam, Netherlands)
Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor
Verified Author affiliations on the Europe PMC record name GSK, Merck & Co. Affiliation source
Disease researchAdded
-
ArticleCell chemical biology
High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleCell chemical biology
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleDiabetes research and clinical practice
Serum adiponectin concentrations as a risk factor for cardiovascular complications in type 1 diabetes
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleiScience
Distinct subsets of neutrophils crosstalk with cytokines and metabolites in patients with sepsis
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleJournal of medicinal chemistry
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleJournal of medicinal chemistry
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS medicinal chemistry letters
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS medicinal chemistry letters
2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Disease researchAdded
-
ArticleACS medicinal chemistry letters
Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity Relationships
Verified Author affiliations on the Europe PMC record name GSK, Merck & Co. Affiliation source
Disease researchAdded